Clinical Trial Detail

NCT ID NCT04182516
Title Study of NMS-03305293 in Pts With Selected Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nerviano Medical Sciences
Indications

prostate cancer

ovary epithelial cancer

pancreatic cancer

Her2-receptor negative breast cancer

Therapies

NMS-03305293

Age Groups: adult senior

No variant requirements are available.